INTRODUCTION
of granulocytes in the circulation, granulocytopenic patients are treated nowadays with recombinant granulocyte colonyBoth radiotherapy and chemotherapy, used for treating neostimulating factor (G-CSF ).2,3 plastic disorders, can suppress the haematopoietic activity of Earlier we developed a mouse model, that in a certain way the bone marrow, that induces leucocytopenia, particularly mimics the effect of prophylactic G-CSF treatment of granulogranulocytopenia. The clinical benefit of accelerated recovery cytopenic patients to prevent infection. Using this model, we from granulocytopenia is a reduction of infectious complireported recently that the effect of G-CSF treatment on the cations, as granulocytes play an essential role in host defence increase in the number of granulocytes in the circulation of against bacterial and fungal infections.1 To increase the number granulocytopenic mice and on the course of bacterial infection in these mice, is dependent on the cause of granulocytopenia.4
The bone marrow contains cells of various lineages in a Quantitation of the number of circulating leucocytes Blood samples were collected in plastic cups containing hepvariety of stages of cell differentiation and maturation. Advances in two-dimensional flow cytometry allows characterarin. The numbers of leucocytes were counted in a Bü rker haemocytometer and the number of granulocytes was deterisation and quantitation of these cell populations.5,6 With the use of two recently described monoclonal antibodies, murine mined by differential count of 200 leucocytes in two Giemsastained blood smears. bone-marrow cells can be separated into at least six morphologically distinct cell populations with a relatively high homogeneity, on the basis of the intensity of antigen expression.7
Quantitation of the number of bone-marrow cells At different time-points before and after infection, mice were This method has shown to be a reliable and efficient tool for monitoring the composition of cell populations in the bone killed and both femurs were removed. The epiphyses were cut off and the marrow was collected by flushing the shafts with marrow of Listerial monocytogenes-infected mice8 and has also been used in a study of bone-marrow cells from granulocytop-2 ml of RPMI medium (Flow Laboratories, Rockville, MD) supplemented with 100 U/ml penicillin G and 50 mg/ml streptoenic mice.9
The aim of the present study was to assess the effect of mycin; then the cells were dispersed into a single cell suspension. The number of cells were counted in a Bü rker G-CSF on the various cell lineages in the bone marrow of mice which have been rendered granulocytopenic by cyclophoshaemocytometer using Tü rk's solution and the number of bone-marrow cells per mouse was calculated under the assumpphamide or sublethal body irradiation and were infected with Staphylococcus aureus. In addition, the effect of G-CSF on the tion that two femurs contain 11·8% of the total murine bone marrow.10 From freshly isolated bone-marrow cells, the mobilisation of granulocytes into the circulation of infected mice has been studied.
erythrocytes were lysed by incubating the cells with lysis buffer (0·2  NH 4 Cl, 0·01  KHCO 3 and 0·1  ethylenediamine tetraacetic acid (EDTA)) for 5 min at RT and washed three times
MATERIALS AND METHODS
with phosphate buffered saline (PBS). Animals Specific pathogen-free female C57Bl/6 mice weighing 20 g, Antibodies and conjugates purchased from IFFA Credo, Saint Germaine-sur-L'Abresle,
The purified monoclonal antibodies (mAb) used in this study France, were used. Sterilised food and tap water were given were ER-MP12 (anti-CD31)4 and ER-MP20 (anti-Ly-6C ).4 ad libitum.
ER-MP12 was conjugated to biotin (N-hydroxysuccinimidobiotin, Boehringer Mannheim GMBH, Mannheim, Induction of granulocytopenia Germany) (ER-MP12-bio+) and ER-MP20 was conjugated Sublethal granulocytopenia was induced by single subcutaneto fluorescein isothiocyanate, isomer I (Sigma Chemical Co., ous (s.c.) injection of 250 mg/kg bodyweight cyclophosphamSt. Louis, MO) (ER-MP20-FITC ). As a second stage fluoide ( Endoxan; Asta Medica B.V., Diemen, The Netherlands) rescent reagent R-phycoerythrin-conjugated streptavidin or by sublethal total body irradiation. The animals, placed in (SAv-PE) (Pharmingen, San Diego, CA) was used, which plexiglass containers, received a total of 5 Gy from a 137Cs binds to ER-MP12-bio+. gamma cell irradiator (Philips SL-75-5/6 MV linear accelerator, Philips Medical Systems, Best, The Netherlands) in the Flow cytometry posterior-anterior and anterior-posterior directions. Both
For phenotyping 5×105 bone-marrow cells from each mouse methods induced the same degree of granulocytopenia (subwere labelled with an optimal concentration of ERlethally) in C57Bl/6 mice.
MP12-bio+ in PBS supplemented with 1% bovine serum albumin (PBS-BSA) for 30 min at 4°, and then washed three Microorganisms times with PBS-BSA. Next, the cells were incubated with Virulent serum-resistant S. aureus (ATCC 25923) were stored optimal concentrations of both ER-MP20-FITC and SAv-PE in tryptose phosphate broth (TPB) (Oxoid Ltd, Basingstoke, simultaneously during 30 min at 4°. After washing the cells UK ) supplemented with 10% dimethyl sulphoxide (DMSO) three times with PBS-BSA, phenotypic analysis was performed at −70°. Samples of the frozen stock were cultured for 18 hr with a FACScan@ cytofluorimeter (Becton Dickinson, at 37°in TPB. Bacteria were collected by centrifugation Sunnyvale, CA). To determine background fluorescence, cells (10 min; 900 g), washed twice in phosphate-buffered saline were incubated with PBS-BSA or only one of the mAbs. (PBS ) and suspended at appropriate bacterial concentrations
In each experiment, bone-marrow cells from naive mice in pyrogen-free saline. The virulence of the bacteria was were used to determine the fluorescence windows that dismaintained by repeated passage through mice.
tinguish six cell populations and these windows were used to gate the cell populations in the bone marrow of mice under Experimental design After induction of granulocytopenia on day 0, mice immedistudy. The relative size of the various cell populations and the total numbers of bone-marrow cells per mouse were used to ately received s.c. injections of 5 mg purified recombinant human G-CSF (rhG-CSF ) (Neupogen, Amgen B.V., Breda, calculate the number of cells of each cell population in the bone marrow of each mouse. The Netherlands) twice a day during 4 days. On day 4 of the experiment, the mice were infected intramuscularly (i.m.) with 5×106 S. aureus into the right thigh muscle. After various
Nomenclature of bone-marrow cell populations
In accordance with previous studies6,7 in naive mice, six cell time intervals blood was taken by puncture of the orbital venous sinus, the animals were killed by CO 2 asphyxiation populations could be defined as summarized in Table 1 . The intensity of antigen expression of ER-MP12 and ER-MP20 is and both femurs were removed. Expression measured by FACS-analysis, hi=high expression; med=mediate expression; +=both high and mediate expression; −=negative expression of ER-MP12 or ER-MP20.
*ER-MP12hi ER-MP20− population consists of morphologically undifferentiated blasts and recognizable blasts of the myeloid, erythroid and lymphoid lineages.
†ER-MP12+ ER-MP20+ population the myeloid blast population ( ER-MP12+ ER-MP20+) contains primarily myeloid blasts, either morphologically undifferentiated or recognizable as such; the vast majority of these cells expresses the myeloid marker Gr-1 (unpublished data).
‡ER-MP12− ER-MP20med population is highly enriched for immature and mature granulocytic cells.
§ER-MP12− ER-MP20hi population consists of mainly immature and mature monocytic cells.
¶ER-MP12med ER-MP20− contains predominantly mature lymphoid cells and a few undifferentiated blasts. **ER-MP12− ER-MP20− population consists of basophilic erythroblasts and more mature nucleated cells of the erythroid lineage.
indicated as: hi=high expression; med=mediate expression; centrifugation and the numbers of granulocytes were determined by differential count of 200 cells in two Giemsa-stained +=both high and mediate expression, and −=negative expression. The nomenclature of the bone-marrow cell bone-marrow cytospin preparations. populations, which are separated on the basis of the intensity Statistical analysis of antigen expression, after staining the cells with the monoThe significance of differences between the obtained data was clonal antibodies ER-MP12 or ER-MP20 and measured by determined by means of the Student's t-test. A value of FACS-analysis (Table 1) , are designated as follows: (1) early P<0·05 was considered significantly different. blasts ( ER-MP12hi ER-MP20−) which include of undifferentiated blasts and cells of the myeloid, erythroid and lymphoid cell-lineages; (2) more differentiated cells of the myeloid cell-RESULTS
lineage ( ER-MP12+ ER-MP20+), particularly myeloid blasts
Changes in the relative size of the various murine bone-marrow either morphologically undifferentiated or recognized as such, cell populations after cyclophosphamide treatment or irradiation from which a vast majority of cells expresses the myeloid in combination with G-CSF treatment marker Gr-1 (P.J.M. Leenen, unpublished data); (3) granulocytic cells (ER-MP12− ER-MP20med ) including band In naive mice, six different cell populations can be distinguished ( Fig. 1a) . At day 4 after cyclophosphamide treatment, the forms and mature granulocytes; (4) Monocytic cells ( ER-MP12− ER-MP20 hi), which contains mainly monocyte relative size of both early and myeloid blast-cell populations was enlarged and that of the granulocytic cell population was precursors and mature monocytes; (5) lymphoid cells ( ER-MP12med ER-MP20−), which contains predominantly markedly reduced (Fig. 1b) compared to that found in the bone marrow of naive mice (Fig. 1a) . After having adminismature lymphocytes and a few undifferentiated blasts; and (6) erythroid cells (ER-MP12− ER-MP20−) consisting of erythrotered G-CSF to cyclophosphamide-treated mice during 4 days, the relative size of the mixed blast population was much larger, blasts and more mature nucleated cells of the erythroid celllineage.
that of the granulocytic cell population was similar and that of the monocytic cells was strongly diminished in the bone marrow (Fig. 1c) compared to those in the bone marrow of Bone marrow culture Nucleated bone-marrow cells were plated in triplicate at a cyclophosphamide-treated mice not given G-CSF (Fig. 1b) . At day 4 after irradiation, the relative size of all cell concentration of 1×104 cells per well in a 96-well plate (Costar) in 100 ml Methocult GF M3534 (Stemcell populations in the bone marrow had not changed (Fig. 1d ) compared to that found in the bone marrow of naive mice Technologies Inc., Vancouver, Canada), which stimulates the growth of granulocyte and macrophage colonies. After 7 days (Fig. 1a) . After 4 days G-CSF treatment to irradiated mice, the relative size of the mixed blast population was much larger, of culture at 37°and 7·5% CO 2 , the cells were gently dispersed into a single cell suspension by dilution in PBS and the number whereas the size of the granulocytic cell population, the monocytic cell population and that of the erythroid cell of cells were counted in a Bü rker haemocytometer using Tü rk's solution. Subsequently cell preparations were made by cytospin population in the bone marrow was much reduced (Fig. 1e ) compared to the respective cell populations in the bone marrow of the other cell populations in the bone marrow were not significantly affected (data not shown). of irradiated mice not given G-CSF (Fig. 1d ) .
After irradiation, the total number of bone-marrow cells decreased from 1·9×108 cells before irradiation to 2·4×107 Effect of G-CSF on the total number of cells in the various bonecells at day 1 and to 2·5×107 cells at day 4 after irradiation, marrow cell populations of cyclophosphamide-treated or i.e. a eight-fold reduction. The total number of granulocytic irradiated mice cells in the bone marrow had decreased threefold and the number of the other cell populations had decreased four-to The number of cells in each bone-marrow cell population in mice was calculated at different time-points after cyclo-40-fold at day 1 after irradiation ( Fig. 2c) . Although the number of granulocytic cells increased at day 7 and decreased phosphamide treatment or irradiation, whether or not combined with G-CSF-treatment. Cyclophosphamide treatment again at day 11, the numbers of the other cell populations changed hardly until day 11 after irradiation (Fig. 2c) . G-CSF decreased the total number of cells in the bone marrow from 1·65×108 cells before treatment to 4·4×107 cells at day 1 and administration to irradiated mice increased the number of myeloid blasts in the bone marrow slightly, but did not affect to 1·5×107 cells at day 4, i.e. a 10-fold reduction. The number of early blasts hardly changed during 5 days of cyclophosthe numbers of any of the various cell populations of the bone marrow (data not shown). phamide treatment (Fig. 2a) . The numbers of myeloid blasts and granulocytic cells had decreased strikingly at day 1 (Fig. 2a) , reaching nadir numbers at day 3, and increased Effect of bacterial infection on the total number of cells of the again after day 3 for the myeloid blasts and after day 4 for various bone-marrow populations in cyclophosphamide-treated the granulocytic cells. The number of monocytic cells decreased or irradiated mice, either treated or not treated with G-CSF also, reaching low numbers at day 2, followed by a small increase after day 4 (Fig. 2a) . The number of lymphoid cells
In cyclophosphamide-treated mice, the total number of bonemarrow cells did not change during the first 4 hr of infection in the bone marrow decreased from 4·8×107 cells before treatment to 1·0×107 cells at day 1 and to 3×106 at day 4 and increased significantly during the next 20 hr. However, a similar result was found in 24 hr non-infected mice. G-CSFafter cyclophosphamide treatment.
After G-CSF administration to cyclophosphamide-treated treatment increased the total number of cells in the bone marrow of cyclophosphamide-treated mice (P<0·01); during mice, the number of early blasts increased slightly and the number of myeloid blasts increased strikingly (P<0·01) after infection in these mice only a slight increase in the total number of bone-marrow cells was found, relative to that in day 2 of G-CSF administration (Fig. 2b) , whereas the numbers non-infected, G-CSF-treated mice (Fig. 3a) . During infection number of granulocytic cells (Fig. 3d ) , and monocytic cells (Fig. 3e) increased, but this increase was similar to that in in irradiated mice, whether or not treated with G-CSF, the total number of bone-marrow cells did not change (Fig. 3a) .
non-infected G-CSF treated mice. In irradiated mice, the number of granulocytic cells The total number of bone-marrow cells of cyclophosphamide-treated or irradiated mice (Fig. 3a) , whether or not, treated ( Fig. 3d ) and monocytic cells (Fig. 3e ) decreased during infection. G-CSF-treatment of irradiated mice increased the number with G-CSF and/or infected with S. aureus, and the relative size of the various bone-marrow cell populations (data not of myeloid blasts (P<0·01) (Fig. 3c) ; however, an infection in these mice did not change the number of any of the boneshown) of these mice were used to calculate the total number of early blasts (Fig. 3b), myeloid blasts (Fig. 3c) , granulocytic marrow cell populations. cells (Fig. 3d ) and monocytic cells (Fig. 3e) in the bone marrow.
During a S. aureus infection in cyclophosphamide-treated
Proliferation of bone-marrow cells in culture mice the number of myeloid blasts (Fig. 3c) increased and the number of monocytic cells ( Fig. 3e) decreased; in these mice To study whether the repopulating ability of the bone-marrow cells is affected by cyclophosphamide treatment, irradiation, also the number of early blasts (Fig. 3b ) and granulocytic cells (Fig. 3d ) increased significantly, however, a similar result was G-CSF-treatment and/or bacterial infection, bone-marrow cells of all these mice under study were cultured in vitro. Bonefound in 24 hr non-infected cyclophosphamide-treated mice. G-CSF-treatment of cyclophosphamide-treated mice increased marrow cells from cyclophosphamide-treated, noninfected mice, had a significantly higher proliferative activity in culture, the number of early blasts (Fig. 3b), myeloid blasts (Fig. 3c ) (P<0·01) and granulocytic cells (Fig. 3d) , and decreased the relative to those of naive mice ( Table 2) . When cyclophosphamide-treated mice were treated with G-CSF, whether or number of monocytic cells (Fig. 3e) . During infection after G-CSF administration to cyclophosphamide-treated mice, the not infected with S. aureus, their bone-marrow cells proliferated significantly more in comparison with those from nonnumber of early blasts decreased (Fig. 3b) , whereas the G-CSF, similarly treated, mice ( Table 2 ). The proliferation of of bone-marrow cells, but, when G-CSF-treated, irradiated, mice were infected for 24 hr, their bone-marrow cells did not bone-marrow cells from S. aureus infected, cylophosphamidetreated mice, was lower than that of non-infected cyclophosproliferate (Table 2) . Because the percentages of granulocytes in the bonephamide-treated mice independent of G-CSF treatment ( Table 2) . marrow cultures from all mice under study were about similar ( Table 2 ), the differences in the total number of granulocytes Bone-marrow cells from irradiated mice, whether or not infected with S. aureus, hardly showed any proliferation during in bone-marrow cell cultures obtained from mice under various experimental conditions showed the same variations as the 7 days of culture (Table 2) . However, G-CSF-treatment of irradiated mice resulted in a significant increased proliferation total number of cells after 7 days of culture ( Table 2) . 
0·4 (0·1) †Mice were treated with cyclophosphamide or irradiated, then treated with G-CSF or vehicle for 4 days and subsequently either or not infected with 5×106 S. aureus in the thigh muscle. Before infection and at 4 and 24 hr after infection, bone-marrow cells from the mice were isolated and 1×104 bone marrow were cultured for 7 days in triplicate, then the total number of cells present and the number of granulocytes were determined. values are mean (SD) of three mice at each time-point. ‡After 7 days of culture granulocyte precursors are differentiated into mature granulocytes. §Significant difference relative to naive mice (P<0·05). **Significant difference comparing G-CSF-treated with non-G-CSF-treated (P<0·01). *Significant difference comparing G-CSF-treated with non-G-CSF-treated; (P<0·05).
Effect of G-CSF on the number of granulocytes in periincreased number of granulocyte precursors in the bone marrow, which can not be identified as a separate class of cells pheral blood of cyclophosphamide or irradiated mice whether or not infected with S. aureus.
with the monoclonal antibodies used. Ultimately this results in a large increase in the number of mature granulocytes, After cyclophosphamide treatment, the number of circulating granulocytes reached nadir values at day 4 (Fig. 4) , which including band forms, in the circulation. However, in irradiated mice, whether or not infected, G-CSF increased only slightly remained unchanged at day 5 (data not shown). During infection of cyclophosphamide-treated mice, the number of the number of myeloid blasts and did not affect the number of circulating granulocytes. The results of the present study blood granulocytes had not changed at 4 hr, but increased (P<0·05) during the next 20 hr, relative to non-infected mice.
are in agreement with our earlier study demonstrating no effect of G-CSF treatment on the course of a S. aureus G-CSF administration to cyclophosphamide-treated mice increased the number of circulating granulocytes (P<0·05) infection of the thigh muscle in sublethally irradiated mice, while in cyclophosphamide-treated mice, that had been admin- (Fig. 4) . In cyclophosphamide-treated, infected mice, which were treated with G-CSF, the number of circulating granuloistered G-CSF, the elimination of bacteria in thigh muscle, spleen and liver was significantly faster compared to non-Gcytes increased 10-fold (P<0·01) at 24 hr compared to noninfected, similarly treated mice (Fig. 4) .
CSF similarly treated mice.4 The results of these in vivo studies are supported by in vitro cultures of bone-marrow cells of the In irradiated mice, the number of circulating granulocytes reached low values at 4 days and during infection the number mice under the various experimental conditions applied. The most striking difference was that in cultures of bone-marrow of blood granulocytes did not change (Fig. 4) . G-CSF treatment of irradiated mice did not affect the number of granulocells from cyclophosphamide-treated, S. aureus-infected mice, that had received G-CSF, the proliferation of granulocyte cytes in the peripheral blood (Fig. 4) .
precursors resulting in mature granulocytes, was many-fold greater than in sublethally irradiated, similarly treated mice.
DISCUSSION
When we speculate about the differences in response to G-CSF treatment between cyclophosphamide-treated and In the present study we focused on the stimulatory effects of G-CSF on various bone-marrow cell populations of granulocyirradiated mice, we may assume that in the bone marrow of cyclophosphamide-treated mice G-CSF-responsive cells are topenic mice, whether or not infected with S. aureus. Differences were found between mice rendered granulostill present, while in irradiated mice these cells can not respond any more or have been eliminated. The difference in response cytopenic by cyclophosphamide treatment or by sublethal irradiation. The main conclusions that could be drawn from to G-CSF between cyclophosphamide-treated and irradiated mice can not be explained by a difference in the degree of these studies are that cyclophosphamide treatment spares the early blast population but affects the other cell populations in granulocytopenia; granulocytopenia was even more severe in the cyclophosphamide-treated mice compared to the the bone marrow, whereas sublethal irradiation affects all bone-marrow cell populations. irradiated mice. Sublethal irradiation of naive mice damaged all subpopulaWhen we consider cyclophosphamide-treated, non-infected mice, G-CSF increased both the number of early and to a tions of the bone marrow, including the early blasts. Irradiation affects only active cycling cells during DNA-synthesis11 and greater extent, the number of myeloid blasts. During an S. aureus infection in these mice, the number of the myeloid the recovery after irradiation is influenced primarily by the surviving, resting stem cells.12-15 In contrast, it is reported that blasts increased further, and conceivably this leads to an bone-marrow cells in the S-phase of cell cycle are more radioproduction of granulocyte precursor cells in the bone marrow induced by G-CSF, because the number of early and myeloid resistant than other cells. 16 In our experiments, cultures of bone-marrow cells from irradiated mice, whether or not treated blasts blasts in the bone marrow of G-CSF-treated mice was about two times higher in comparison with that in the bone with G-CSF, did not show any substantial increase, but also no decrease in cell number, which indicates that a great marrow of non-G-CSF-treated, cyclophosphamide-treated mice. However, an increase of immature circulating granulomajority of dividing cells, probably cells not in S-phase, are affected by irradiation.
cytes after cyclophosphamide treatment, whether or not combined with G-CSF administration, has been reported Apparently, in vivo, the delay of bone-marrow recovery exhibited by the increase in the numbers of bone-marrow cells recently. [24] [25] [26] The mechanisms underlying the mobilization of mature and immature cells from bone marrow into the and circulating granulocytes after G-CSF treatment differed also between irradiated and cyclophosphamide-treated mice.
circulation are unknown as yet. After irradiation and G-CSF treatment bone-marrow recovery did not occur during the first 11 days, while after cyclophos-ACKNOWLEDGMENTS phamide and G-CSF treatment the number of bone-marrow cells increased after day 4. This delay in bone-marrow recovery This study was financially supported by the J. H. Cohen Institute for Radiopathology and Radioprotection.
can explain the absence of an effect of G-CSF treatment on the number of circulating granulocytes after irradiation. However, others have described radioprotective effects of REFERENCES G-CSF on the survival of mice after lethal body irradiation,17-19 but these data were obtained from days 12-21 regeneration of murine hematopoietic stem cells after total body granulocyte colony-stimulating factor modifies radiation-induced death in B 
